Literature DB >> 9650033

DSM-IV hypochondriasis in primary care.

J I Escobar1, M Gara, H Waitzkin, R C Silver, A Holman, W Compton.   

Abstract

The object of this study was to assess the prevalence and correlates of the DSM-IV diagnosis of hypochondriasis in a primary care setting. A large sample (N = 1456) of primary care users was given a structured interview to make diagnoses of mood, anxiety, and somatoform disorders and estimate levels of disability. The prevalence of hypochondriasis (DSM-IV) was about 3%. Patients with this disorder had higher levels of medically unexplained symptoms (abridged somatization) and were more impaired in their physical functioning than patients without the disorder. Of the various psychopathologies examined, major depressive syndromes were the most frequent among patients with hypochondriasis. Interestingly, unlike somatization disorder, hypochondriasis was not related to any demographic factor. Hypochondriasis is a relatively rare condition in primary care that is largely separable from somatization disorder but seems closely intertwined with the more severe depressive syndromes.

Entities:  

Mesh:

Year:  1998        PMID: 9650033     DOI: 10.1016/s0163-8343(98)00018-8

Source DB:  PubMed          Journal:  Gen Hosp Psychiatry        ISSN: 0163-8343            Impact factor:   3.238


  12 in total

Review 1.  Should an obsessive-compulsive spectrum grouping of disorders be included in DSM-V?

Authors:  Katharine A Phillips; Dan J Stein; Scott L Rauch; Eric Hollander; Brian A Fallon; Arthur Barsky; Naomi Fineberg; David Mataix-Cols; Ygor Arzeno Ferrão; Sanjaya Saxena; Sabine Wilhelm; Megan M Kelly; Lee Anna Clark; Anthony Pinto; O Joseph Bienvenu; Joanne Farrow; James Leckman
Journal:  Depress Anxiety       Date:  2010-06       Impact factor: 6.505

2.  The factor structure of the illness attitude scales in a German population.

Authors:  Florian Weck; Gaby Bleichhardt; Wolfgang Hiller
Journal:  Int J Behav Med       Date:  2009

3.  CHAMP: Cognitive behaviour therapy for health anxiety in medical patients, a randomised controlled trial.

Authors:  Peter Tyrer; Sylvia Cooper; Helen Tyrer; Paul Salkovskis; Mike Crawford; John Green; Georgina Smith; Steven Reid; Simon Dupont; David Murphy; Sarah Byford; Duolao Wang; Barbara Barrett
Journal:  BMC Psychiatry       Date:  2011-06-14       Impact factor: 3.630

Review 4.  Epidemiology and treatment of hypochondriasis.

Authors:  Mónica Magariños; Uzma Zafar; Kore Nissenson; Carlos Blanco
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

5.  The outcome of health anxiety in primary care. A two-year follow-up study on health care costs and self-rated health.

Authors:  Per Fink; Eva Ørnbøl; Kaj Sparle Christensen
Journal:  PLoS One       Date:  2010-03-24       Impact factor: 3.240

6.  Do psychiatric comorbidities influence inpatient death, adverse events, and discharge after lower extremity fractures?

Authors:  Mariano E Menendez; Valentin Neuhaus; Arjan G J Bot; Mark S Vrahas; David Ring
Journal:  Clin Orthop Relat Res       Date:  2013-06-30       Impact factor: 4.176

7.  Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation.

Authors:  Joanna Leaviss; Sarah Davis; Shijie Ren; Jean Hamilton; Alison Scope; Andrew Booth; Anthea Sutton; Glenys Parry; Marta Buszewicz; Rona Moss-Morris; Peter White
Journal:  Health Technol Assess       Date:  2020-09       Impact factor: 4.014

8.  Cyberchondria: Parsing Health Anxiety From Online Behavior.

Authors:  Emily R Doherty-Torstrick; Kate E Walton; Brian A Fallon
Journal:  Psychosomatics       Date:  2016-02-04       Impact factor: 2.386

9.  The factor structure and reliability of the Illness Attitude Scales in a student and a patient sample.

Authors:  Alexander Crössmann; Paul Pauli
Journal:  BMC Psychiatry       Date:  2006-10-26       Impact factor: 3.630

10.  Follow-up study on health care use of patients with somatoform, anxiety and depressive disorders in primary care.

Authors:  Margot W M de Waal; Ingrid A Arnold; Just A H Eekhof; Willem J J Assendelft; Albert M van Hemert
Journal:  BMC Fam Pract       Date:  2008-01-24       Impact factor: 2.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.